These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37922359)

  • 1. The STEMRI trial: Magnetic resonance spectroscopy imaging can define tumor areas enriched in glioblastoma stem-like cells.
    Lemarié A; Lubrano V; Delmas C; Lusque A; Cerapio JP; Perrier M; Siegfried A; Arnauduc F; Nicaise Y; Dahan P; Filleron T; Mounier M; Toulas C; Cohen-Jonathan Moyal E
    Sci Adv; 2023 Nov; 9(44):eadi0114. PubMed ID: 37922359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the lactate-to-N-acetyl-aspartate ratio defined with magnetic resonance spectroscopic imaging before radiation therapy as a new predictive marker of the site of relapse in patients with glioblastoma multiforme.
    Deviers A; Ken S; Filleron T; Rowland B; Laruelo A; Catalaa I; Lubrano V; Celsis P; Berry I; Mogicato G; Cohen-Jonathan Moyal E; Laprie A
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):385-93. PubMed ID: 25104068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of recurrence analysis in newly diagnosed glioblastoma multiforme after three-dimensional conformal radiation therapy with respect to pre-radiation therapy magnetic resonance spectroscopic findings.
    Park I; Tamai G; Lee MC; Chuang CF; Chang SM; Berger MS; Nelson SJ; Pirzkall A
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):381-9. PubMed ID: 17513061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI.
    Pirzkall A; Li X; Oh J; Chang S; Berger MS; Larson DA; Verhey LJ; Dillon WP; Nelson SJ
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):126-37. PubMed ID: 15093908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy.
    Pirzkall A; Nelson SJ; McKnight TR; Takahashi MM; Li X; Graves EE; Verhey LJ; Wara WW; Larson DA; Sneed PK
    Int J Radiat Oncol Biol Phys; 2002 Aug; 53(5):1254-64. PubMed ID: 12128127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of Glioma Stemlike Cell Infiltration in the Non-Contrast-Enhancing Area by Quantitative Measurement of Lactate on Magnetic Resonance Spectroscopy in Glioblastoma.
    Inoue A; Nishikawa M; Ohnishi T; Yano H; Kanemura Y; Ohtsuka Y; Ozaki S; Nakamura Y; Matsumoto S; Suehiro S; Yamashita D; Shigekawa S; Watanabe H; Kitazawa R; Tanaka J; Kunieda T
    World Neurosurg; 2021 Sep; 153():e76-e95. PubMed ID: 34144167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.
    Wakimoto H; Mohapatra G; Kanai R; Curry WT; Yip S; Nitta M; Patel AP; Barnard ZR; Stemmer-Rachamimov AO; Louis DN; Martuza RL; Rabkin SD
    Neuro Oncol; 2012 Feb; 14(2):132-44. PubMed ID: 22067563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extending the resection beyond the contrast-enhancement for glioblastoma: feasibility, efficacy, and outcomes.
    Mampre D; Ehresman J; Pinilla-Monsalve G; Osorio MAG; Olivi A; Quinones-Hinojosa A; Chaichana KL
    Br J Neurosurg; 2018 Oct; 32(5):528-535. PubMed ID: 30073866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton magnetic resonance spectroscopic imaging in newly diagnosed glioblastoma: predictive value for the site of postradiotherapy relapse in a prospective longitudinal study.
    Laprie A; Catalaa I; Cassol E; McKnight TR; Berchery D; Marre D; Bachaud JM; Berry I; Moyal EC
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):773-81. PubMed ID: 18262090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioblastoma Stem-like Cell Detection Using Perfusion and Diffusion MRI.
    Duval T; Lotterie JA; Lemarie A; Delmas C; Tensaouti F; Moyal EC; Lubrano V
    Cancers (Basel); 2022 Jun; 14(11):. PubMed ID: 35681782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stemness Marker Detection in the Periphery of Glioblastoma and Ability of Glioblastoma to Generate Glioma Stem Cells: Clinical Correlations.
    Raysi Dehcordi S; Ricci A; Di Vitantonio H; De Paulis D; Luzzi S; Palumbo P; Cinque B; Tempesta D; Coletti G; Cipolloni G; Cifone MG; Galzio R
    World Neurosurg; 2017 Sep; 105():895-905. PubMed ID: 28559081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1H NMR detects different metabolic profiles in glioblastoma stem-like cells.
    Guidoni L; Ricci-Vitiani L; Rosi A; Palma A; Grande S; Luciani AM; Pelacchi F; di Martino S; Colosimo C; Biffoni M; De Maria R; Pallini R; Viti V
    NMR Biomed; 2014 Feb; 27(2):129-45. PubMed ID: 24142746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glioblastoma Stem Cell-Derived Exosomes Enhance Stemness and Tumorigenicity of Glioma Cells by Transferring Notch1 Protein.
    Sun Z; Wang L; Zhou Y; Dong L; Ma W; Lv L; Zhang J; Wang X
    Cell Mol Neurobiol; 2020 Jul; 40(5):767-784. PubMed ID: 31853695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiating Glioblastoma from Primary Central Nervous System Lymphoma: The Value of Shaping and Nonenhancing Peritumoral Hyperintense Gyral Lesion on FLAIR Imaging.
    Wang P; Shi YH; Li JY; Zhang CZ
    World Neurosurg; 2021 May; 149():e696-e704. PubMed ID: 33548537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential value of MR spectroscopic imaging for the radiosurgical management of patients with recurrent high-grade gliomas.
    Chuang CF; Chan AA; Larson D; Verhey LJ; McDermott M; Nelson SJ; Pirzkall A
    Technol Cancer Res Treat; 2007 Oct; 6(5):375-82. PubMed ID: 17877425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ion channel expression patterns in glioblastoma stem cells with functional and therapeutic implications for malignancy.
    Pollak J; Rai KG; Funk CC; Arora S; Lee E; Zhu J; Price ND; Paddison PJ; Ramirez JM; Rostomily RC
    PLoS One; 2017; 12(3):e0172884. PubMed ID: 28264064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Glioblastoma Tumor-Propagating Cells by the Integrin Partner Tetraspanin CD151.
    Tilghman J; Schiapparelli P; Lal B; Ying M; Quinones-Hinojosa A; Xia S; Laterra J
    Neoplasia; 2016 Mar; 18(3):185-98. PubMed ID: 26992919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human glioblastoma stem-like cells accumulate protoporphyrin IX when subjected to exogenous 5-aminolaevulinic acid, rendering them sensitive to photodynamic treatment.
    Schimanski A; Ebbert L; Sabel MC; Finocchiaro G; Lamszus K; Ewelt C; Etminan N; Fischer JC; Sorg RV
    J Photochem Photobiol B; 2016 Oct; 163():203-10. PubMed ID: 27588717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (1) H NMR spectroscopy of glioblastoma stem-like cells identifies alpha-aminoadipate as a marker of tumor aggressiveness.
    Rosi A; Ricci-Vitiani L; Biffoni M; Grande S; Luciani AM; Palma A; Runci D; Cappellari M; De Maria R; Guidoni L; Pallini R; Viti V
    NMR Biomed; 2015 Mar; 28(3):317-26. PubMed ID: 25581615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival analysis in patients with newly diagnosed glioblastoma using pre- and postradiotherapy MR spectroscopic imaging.
    Li Y; Lupo JM; Parvataneni R; Lamborn KR; Cha S; Chang SM; Nelson SJ
    Neuro Oncol; 2013 May; 15(5):607-17. PubMed ID: 23393206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.